| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/14/2004 | EP1301522A4 Novel compounds and methods |
| 04/14/2004 | EP1274426B1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP1140072B1 Compounds and methods |
| 04/14/2004 | EP1115708B1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489460A Remedies/preventives for in flammatory diseases |
| 04/14/2004 | CN1488638A Barrenwort total falvone extracting method and product made from said extract |
| 04/14/2004 | CN1488391A Medicine for treating waist and lower extremities pain |
| 04/14/2004 | CN1488388A Chinese medicine compositior for treating intervertebral disc osteoproliferation |
| 04/14/2004 | CN1488375A Chinese medicine for treating bony spur, cervical vertebra and lumber intervertebral disc protrasion |
| 04/14/2004 | CN1488374A Medicinal liquor for traumatic injuries |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/14/2004 | CN1145606C 2-aminotetrahydronaphthalene, process for their preparation, and pharmaceutical composition for prevention and therapeutic treatment of in flammatory and lor autoimmune pathologies |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720354 Prevention of neutrophil recruitment |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029046A2 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004029036A1 Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof |
| 04/08/2004 | WO2004028545A1 A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| 04/08/2004 | WO2004028526A1 Therapeutic agent for rheumatism containing benzamide derivative as active ingredient |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004005350A3 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003094617A3 Use of vegf for treating bone defects |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003078647A3 Aza-benzothiopyranoindazoles with antitumor activity |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068129 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067253 Pharmaceutical preparation, method for its production as well as its use |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067231 Agents for ameliorating symtoms caused by joint diseases |
| 04/08/2004 | CA2499819A1 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/07/2004 | EP1405861A2 Analogs of parathyroid hormone |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404868A2 Compositions and methods relating to osteoarthritis |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404701A1 Method for preparing oestrogen derivatives |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |